Tag Archives: first

FDA Approves Imbruvica (ibrutinib) Plus Obinutuzumab as First Non-Chemotherapy Combination Regimen for Treatment-Naïve Patients with Chronic Lymphocytic Leukemia

Print this page HORSHAM, Pa., Jan. 28, 2019 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) approval of Imbruvica (ibrutinib) in combination with obinutuzumab in treatment-naïve patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), the most common form of leukemia in adults.1 This is… Read More »

First Device for Predicting Risk of Pressure Ulcers FDA Cleared

January 4th, 2019 Editors Critical Care, Medicine, Plastic Surgery, Surgery, Vascular Surgery Pressure ulcers are a common malady for bedridden patients, a situation that clinicians have been struggling to improve significantly. There are devices that sense how long a part of a body has been pressed on for too long, beds that deflate and inflate… Read More »